Table 4.
Patients’ Characteristics
| N=39 | |
|---|---|
| Age, y | 70.0±1.8 |
| Male sex | 25 (64) |
| Hypertension | 30 (77) |
| Dyslipidemia | 23 (59) |
| Diabetes mellitus | 13 (33) |
| Current smoking | 17 (44) |
| Obesity (BMI >25) | 12 (31) |
| Family history of CAD | 8 (21) |
| OMI | 2 (5) |
| STEMI/NSTEMI | 29/10 (74/26) |
| Multivessel disease | 21 (54) |
| Total cholesterol, mg/dL | 168.6±5.0 |
| LDL cholesterol, mg/dL | 98.3±4.4 |
| HDL cholesterol, mg/dL | 43.9±2.4 |
| Triglyceride, mg/dL | 87.3±9.1 |
| HbA1c, % | 6.4±0.2 |
| Glucose, mg/dL | 172.7±11.2 |
| CK on admission, IU/mL | 350.6±120.0 |
| Peak CK, IU/mL | 2140.2±311.5 |
| CCB | 16 (41) |
| RAS‐I | 12 (31) |
| β‐blocker | 2 (5) |
| Statin | 7 (18) |
| Anti‐DM | 6 (15) |
| Insulin | 2 (5) |
All values are n (%) or mean±SEM. BMI, body mass index; CAD, coronary artery disease; CCB, calcium channel blocker; CK, creatine kinase; DM, diabetes mellitus; HbA1c, hemoglobin A1c; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; NSTEMI, non–ST‐segment elevation myocardial infarction; OMI, old myocardial infarction; RAS‐I, renin–angiotensin system inhibitor, STEMI, ST‐segment elevation myocardial infarction.